Boston Scientific gets FDA approval for Liberté stent

AuntMinnie.com staff writers
Apr 13, 2005

Interventional device manufacturer Boston Scientific said that it has received Food and Drug Administration approval for its Liberté bare-metal coronary stent system.

The Liberté stent serves as the platform for Boston Scientific's paclitaxel-eluting stent system, Taxus Liberté. Boston Scientific plans to launch the Liberté stent immediately in the U.S., according to the Natick, MA-based firm.

By AuntMinnie.com staff writers
April 14, 2005

Related Reading

Boston Scientific initiates Syntax trial, April 12, 2005

Boston Scientific adds CE Mark, April 6, 2005

Boston Scientific gets FDA OK for Taxus in MRI, April 5, 2005

Boston Scientific loses stent verdict, March 25, 2005

Boston Scientific continues robust growth, February 1, 2005

Copyright © 2005 AuntMinnie.com

Latest in Interventional
Emergency 400
Ultrasound-guided nerve blocks safe for emergency pain management
November 13, 2024
Thyroid Cancer
Thermal ablation effective long term in patients with thyroid cancer
November 7, 2024
Lawsuit 6511c4190f4c2
Mass. radiology provider may be liable for 'unavailable' IR physician
October 28, 2024
Knee
GAE could be cost-effective for knee osteoarthritis
September 26, 2024
Related Stories
187x200 Am Logo
Companies
AuntMinnie.com
2004 07 07 11 45 04 706
Interventional
Radiologists seek to optimize PICC line placement
2004 06 25 15 06 10 706
Interventional
Two studies tailor gynecologic imaging, intervention
2003 11 17 15 44 55 706
Interventional
Radiologists and surgeons fractured over vertebroplasty vs. kyphoplasty
More in Interventional
Ultrasound-guided nerve blocks safe for emergency pain management
By Amerigo Allegretto
Ultrasound-guided nerve blocks (UGNBs) performed by emergency clinicians could be safe for pain management.
November 13, 2024
Emergency 400
Thermal ablation effective long term in patients with thyroid cancer
By Will Morton
Outcomes over 10 years suggest that image-guided thermal ablation is a safe and effective option for patients with papillary thyroid carcinoma.
November 7, 2024
Thyroid Cancer
Mass. radiology provider may be liable for 'unavailable' IR physician
By Kate Madden Yee
The Massachusetts Court of Appeals has ruled that a radiology services provider could be held liable for failing to provide a patient with access to an on-call interventional radiologist.
October 28, 2024
Lawsuit 6511c4190f4c2
GAE could be cost-effective for knee osteoarthritis
By Will Morton
Genicular artery embolization (GAE) is likely a cost-effective treatment for symptomatic knee osteoarthritis.
September 26, 2024
Knee
PAE mitigates enlarged prostate symptoms after 2 years
By Will Morton
Men with enlarged prostates who undergo minimally invasive prostatic artery embolization (PAE) have significant improvements in symptoms after two years.
September 5, 2024
Prostate Imaging
Acute stroke intervention results in long-term benefits
By Will Morton
The benefits of endovascular thrombectomy in patients with acute basilar artery occlusion are sustained at long-term follow-up.
August 26, 2024
Stroke Evt
Should there be an age limit for performing EVT in stroke patients?
By Will Morton
Could a fixed upper age limit be justified for performing endovascular thrombectomies (EVT) to treat the oldest elderly stroke patients?
August 12, 2024
Evt
Cryoneurolysis effective for pain control after rib fractures
By Will Morton
CT-guided cryoneurolysis – the freezing of nerves to alleviate pain – is safe and effective in older adults with rib fractures.
August 7, 2024
I Rs2
Cryoablation safe, effective in treating soft-tissue sarcoma
By Amerigo Allegretto
Percutaneous cryoablation is safe and effective for patients with recurrent or metastatic soft-tissue sarcoma after earlier treatments.
August 1, 2024
(A) Axial noncontrast CT chest image shows soft tissue mass in the anterior chest wall (arrow). The lesion was treated by percutaneous cryoablation. (B) Intraprocedural axial CT image obtained during cryoablation. The pink outline represents the target lesion and the blue outline represents ice ball. Based on review, the procedure was classified as achieving adequate ablation. (C) Axial contrast-enhanced CT chest image, obtained three months after ablation (patient’s first follow-up exam), shows involution of the target lesion without evidence of residue. Image courtesy of the ARRS.
A few interventional radiologists get lion's share of industry payments
By Erik L. Ridley
A very small percentage of interventional radiologists are benefitting the most from industry payments.
July 24, 2024
Dollars Pile
Cryoablation safe and effective for treating breast cancer
By Amerigo Allegretto
Cryoablation is a safe, effective treatment method for breast cancer, new research suggests.
July 11, 2024
Breast Cancer 3 D
Many women unaware of treatment options for uterine fibroids
By Amerigo Allegretto
Over 50% of women diagnosed with uterine fibroids have been offered hysterectomy, while fewer than 20% are presented with other options.
July 9, 2024
Uterus Pelvic Social
Page 1 of 181
Next Page